Novartis Investigative Site

Izmir, Karabaglar 35170

0 studies enrolling now · 2 studies all time

What they study most

Chronic Spontaneous Urticaria, Relapsing Multiple Sclerosis

Studies at this site

• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib — Running, not enrolling